Announcement on Change of Accounting Policies
Filed with SSE · · 2 pages · Chinese
Tasly Pharmaceutical Group Co. Ltd. on 6ix
Earlier from Tasly Pharmaceutical
- Announcement on Resolutions of the 2025 Annual General Meeting
- Announcement on Guarantee Estimate for 2026
- Announcement on Annual Key Operating Data Report for 2025
- Announcement on Resignation of Senior Management Member
- Preliminary Earnings Estimate for 2025
Later from Tasly Pharmaceutical
- Announcement on Convening Performance Briefing for 2025 and Q1 2026
- Announcement on Implementation of Dividend Distribution for 2025
- Announcement on Remuneration Plan for Directors and Senior Management Members in 2026
- Announcement on Obtaining Drug Registration Certificate by Subsidiary
- Announcement on Resolutions of the 1st Extraordinary General Meeting in 2026
Follow Tasly Pharmaceutical into a list and get an email when it puts out news.
Follow Tasly Pharmaceutical